Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
87,692,308
-
Total 13F shares
-
17,905,204
-
Share change
-
+17,880,204
-
Total reported value
-
$393,648,000
-
Price per share
-
$22.00
-
Number of holders
-
41
-
Value change
-
+$393,098,000
-
Number of buys
-
40
Institutional Holders of Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN) as of Q1 2021
As of 31 Mar 2021,
Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,905,204 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, Vivo Capital, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), SUVRETTA CAPITAL MANAGEMENT, LLC, MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, Antara Capital LP, VANGUARD GROUP INC, Samsara BioCapital, LLC, and BlackRock Inc..
This page lists
41
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.